The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 28, 2018
Filed:
Mar. 13, 2014
Applicant:
Glaxosmithkline Biologicals S.a., Rixensart, BE;
Inventors:
Guy Baudoux, Rixensart, BE;
Mathieu Boxus, Rixensart, BE;
Brigitte Colau, Rixensart, BE;
Martine Marchand, Rixensart, BE;
Assignee:
GlaxoSmithKline Biologicals S.A., Rixensart, BE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/125 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01); C12N 7/00 (2006.01); C07K 14/085 (2006.01); A61K 39/39 (2006.01); C07K 7/08 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
A61K 39/125 (2013.01); A61K 39/12 (2013.01); A61K 39/39 (2013.01); C07K 7/08 (2013.01); C07K 14/005 (2013.01); C07K 14/085 (2013.01); C12N 7/00 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/6081 (2013.01); A61K 2039/64 (2013.01); C12N 2770/32034 (2013.01); C12N 2770/32334 (2013.01); C12N 2770/32722 (2013.01); C12N 2770/32734 (2013.01);
Abstract
The disclosure provides immunogenic compositions comprising human picornavirus peptides derived from structural proteins of the virus, constructs comprising the peptides, the peptides themselves and their use in the prevention of picornavirus infection and disease. Particular peptides from VP4 and VP1 are disclosed.